Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Otolaryngology

Biology, Anatomy, and Sinus Subtypes

At a Glance

Chronic ethmoidal sinusitis is long-term inflammation of the honeycomb-like sinus cavities between the eyes. The condition is primarily categorized by whether nasal polyps are present (CRSwNP) or absent (CRSsNP). Identifying the exact subtype is crucial for choosing targeted therapies.

Understanding chronic ethmoidal sinusitis starts with the unique “neighborhood” where it lives. The ethmoid sinuses are not just two large cavities; they are a complex network of small, air-filled chambers located between your eyes and the bridge of your nose.

The “Honeycomb” and the “Drainage Hub”

The ethmoid sinus is often described as a honeycomb because it consists of 7 to 15 small “air cells” on each side [1]. Because of its central location, it serves as the gateway for your other sinuses.

The most critical area in this region is the osteomeatal complex (OMC). Think of the OMC as a central drainage hub or a busy highway interchange. It is the narrow passage where the larger frontal sinuses (forehead) and maxillary sinuses (cheeks) drain into the nose [2]. Because this area is so small, even a tiny amount of swelling or a structural variation in the ethmoid air cells can block the “highway,” causing a backup of mucus and inflammation in all the connected sinuses [3].

Two Major Subtypes: CRSsNP vs. CRSwNP

Doctors generally divide chronic rhinosinusitis (CRS) into two categories based on what they see during an exam:

  1. CRSsNP (Without Nasal Polyps): This is the more common form. It involves long-term inflammation and thickening of the sinus lining, but no growths are present. It is often driven by a mix of different inflammatory patterns [4].
  2. CRSwNP (With Nasal Polyps): In this form, the inflammation is so intense that the sinus lining swells into soft, grape-like growths called nasal polyps. This subtype is frequently driven by Type 2 inflammation [5].

Type 2 inflammation is a specific immune system “overdrive” involving chemical messengers called IL-4 and IL-13 [6]. This pathway recruits specialized white blood cells called eosinophils to the sinus tissue, which contributes to the growth of polyps and a significant loss of smell [7][8].

Specialized Conditions: AERD and AFRS

Some patients fall into more specific, aggressive categories of sinus disease that require specialized care:

  • AERD (Aspirin-Exacerbated Respiratory Disease): Also known as Samter’s Triad, this condition consists of three things: nasal polyps, asthma, and a severe respiratory reaction to aspirin or other NSAIDs (like ibuprofen) [9]. AERD is characterized by very high levels of Type 2 inflammation and a high rate of polyps returning even after surgery [10][11].
  • AFRS (Allergic Fungal Rhinosinusitis): This is not a fungal infection in the traditional sense, but rather an intense allergic reaction to common fungi in the air [12]. Patients with AFRS develop a very thick, “peanut butter-like” mucus (eosinophilic mucin) that can actually expand the sinus walls over time [12][13].

Identifying these subtypes is vital because they often respond better to targeted treatments—such as biologics that block Type 2 pathways—than to standard antibiotics alone [6][14].

Common questions in this guide

What is the osteomeatal complex and why is it important?
The osteomeatal complex is the narrow central drainage hub where your larger facial sinuses empty into your nose. When swelling or structural issues block this small area, it causes a backup of mucus and inflammation in the connected sinuses.
What is the difference between CRSsNP and CRSwNP?
These are the two main types of chronic rhinosinusitis. CRSsNP involves long-term sinus inflammation without any growths. CRSwNP involves intense inflammation that causes soft, grape-like nasal polyps to form in the sinus lining.
What role does Type 2 inflammation play in sinus disease?
Type 2 inflammation is an immune system overreaction that brings specialized white blood cells to the sinus tissue. It is a major driver of nasal polyp growth and often causes a severe loss of smell.
How do I know if I should be tested for AERD?
You should discuss AERD with your doctor if you have nasal polyps, asthma, and have experienced a respiratory reaction or worsening symptoms after taking aspirin or NSAIDs like ibuprofen.
What is Allergic Fungal Rhinosinusitis (AFRS)?
AFRS is an intense allergic reaction to common airborne fungi, rather than a traditional fungal infection. It is characterized by the production of extremely thick, peanut butter-like mucus that can actually expand the sinus walls over time.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my CT scan, is the osteomeatal complex (the drainage hub) blocked on one or both sides?
  2. 2.Do I have nasal polyps (CRSwNP), and if so, does my tissue show signs of Type 2 inflammation?
  3. 3.Should I be tested for AERD if I have asthma and have noticed reactions to aspirin or ibuprofen?
  4. 4.Does the mucus in my sinuses show any signs of fungal hypersensitivity that could indicate AFRS?
  5. 5.Would a biologic treatment targeting Type 2 inflammation, like an IL-4/IL-13 inhibitor, be appropriate for my specific subtype?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    A juxta-ethmoidal course of the infraorbital canal in cases with large ethmomaxillary sinuses or giant Haller cells.

    Rusu MC, Vrapciu AD, Tudose RC

    Anatomy & cell biology 2025; (58(4)):647-651 doi:10.5115/acb.25.144.

    PMID: 41140064
  2. 2

    Osteomeatal Complex: A Study of Its Anatomical Variation Among Patients Attending North Bengal Medical College and Hospital.

    Bandyopadhyay R, Biswas R, Bhattacherjee S, et al.

    Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2015; (67(3)):281-6 doi:10.1007/s12070-015-0874-z.

    PMID: 26405665
  3. 3

    Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity.

    Arnaoutakis D, Naseri I

    Journal of neurological surgery reports 2015; (76(2)):e233-8 doi:10.1055/s-0035-1562852.

    PMID: 26623233
  4. 4

    Exploring the immunopathology of type 2 inflammatory airway diseases.

    AlBloushi S, Al-Ahmad M

    Frontiers in immunology 2024; (15()):1285598 doi:10.3389/fimmu.2024.1285598.

    PMID: 38680486
  5. 5

    The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps.

    Bachert C, Hicks A, Gane S, et al.

    Frontiers in immunology 2024; (15()):1356298 doi:10.3389/fimmu.2024.1356298.

    PMID: 38690264
  6. 6

    Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.

    Hopkins C, Wagenmann M, Bachert C, et al.

    International forum of allergy & rhinology 2021; (11(7)):1087-1101 doi:10.1002/alr.22780.

    PMID: 33611847
  7. 7

    Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement.

    Lou H, Zhang N, Bachert C, Zhang L

    International forum of allergy & rhinology 2018; (8(11)):1218-1225 doi:10.1002/alr.22214.

    PMID: 30296011
  8. 8

    Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds.

    Chuang CC, Guillemin I, Bachert C, et al.

    The Laryngoscope 2022; (132(2)):259-264 doi:10.1002/lary.29911.

    PMID: 34817082
  9. 9

    Treatment practices for aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.

    Roland LT, Nagy C, Wang H, et al.

    International forum of allergy & rhinology 2020; (10(2)):190-193 doi:10.1002/alr.22471.

    PMID: 31693796
  10. 10

    Immune endotyping and gene expression profile of patients with chronic rhinosinusitis with nasal polyps in the aspirin-exacerbated respiratory disease (AERD) and the non-AERD subgroups.

    Nazari J, Shahba F, Jafariaghdam N, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2024; (20(1)):14 doi:10.1186/s13223-024-00876-w.

    PMID: 38360807
  11. 11

    Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?

    O'Brien EK, Jerschow E, Divekar RD

    Otolaryngologic clinics of North America 2024; (57(2)):265-278 doi:10.1016/j.otc.2023.09.006.

    PMID: 37833102
  12. 12

    Allergic Fungal Rhinosinusitis.

    Hoyt AE, Borish L, Gurrola J, Payne S

    The journal of allergy and clinical immunology. In practice 2016; (4(4)):599-604.

    PMID: 27393774
  13. 13

    Reducing Fungal Exposure Critical for Treating Rhinosinusitis with or without Polyps [Response to Letter].

    Bachert C, Bhattacharyya N, Desrosiers M, Khan AH

    Journal of asthma and allergy 2021; (14()):393-395 doi:10.2147/JAA.S314846.

    PMID: 33907424
  14. 14

    IL-4Rα signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease.

    Chen CC, Buchheit KM, Lee PY, et al.

    The Journal of allergy and clinical immunology 2024; (154(2)):458-467.e3 doi:10.1016/j.jaci.2024.04.020.

    PMID: 38704098

This page provides general educational information about chronic ethmoidal sinusitis anatomy and subtypes. It is not intended as medical advice; always consult an ENT or allergist for diagnosis and treatment.

Get notified when new evidence is published on chronic ethmoidal sinusitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.